201231_Top_Holders_Report (91) Categories: News & Announcements 2020, Top 20 ShareholdersBy Richard MollardJanuary 4, 2021Related postsDecember 23, PharmAust Commences MPL Manufacture for Human Clinical TrialsDecember 23, 2020December 22, PharmAust Set to Commence Phase IIb Anticancer Canine TrialDecember 22, 2020December 21, Epichem Awarded DNDi ExtensionDecember 21, 2020December 4, Issued CapitalDecember 4, 2020November 30, Top 20 ShareholdersDecember 1, 2020November 5, AGM ResultsNovember 5, 2020